1. Home
  2. ELPC vs BLCO Comparison

ELPC vs BLCO Comparison

Compare ELPC & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELPC
  • BLCO
  • Stock Information
  • Founded
  • ELPC 1954
  • BLCO 1853
  • Country
  • ELPC Brazil
  • BLCO Canada
  • Employees
  • ELPC N/A
  • BLCO N/A
  • Industry
  • ELPC Electric Utilities: Central
  • BLCO Ophthalmic Goods
  • Sector
  • ELPC Utilities
  • BLCO Health Care
  • Exchange
  • ELPC Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • ELPC 5.1B
  • BLCO 5.6B
  • IPO Year
  • ELPC N/A
  • BLCO 2022
  • Fundamental
  • Price
  • ELPC $6.92
  • BLCO $12.99
  • Analyst Decision
  • ELPC
  • BLCO Hold
  • Analyst Count
  • ELPC 0
  • BLCO 12
  • Target Price
  • ELPC N/A
  • BLCO $18.73
  • AVG Volume (30 Days)
  • ELPC 24.7K
  • BLCO 700.9K
  • Earning Date
  • ELPC 01-01-0001
  • BLCO 04-30-2025
  • Dividend Yield
  • ELPC 4.10%
  • BLCO N/A
  • EPS Growth
  • ELPC 17.98
  • BLCO N/A
  • EPS
  • ELPC 0.15
  • BLCO N/A
  • Revenue
  • ELPC $3,662,312,415.00
  • BLCO $4,791,000,000.00
  • Revenue This Year
  • ELPC $0.98
  • BLCO $6.43
  • Revenue Next Year
  • ELPC $6.83
  • BLCO $5.59
  • P/E Ratio
  • ELPC $11.65
  • BLCO N/A
  • Revenue Growth
  • ELPC 5.45
  • BLCO 15.56
  • 52 Week Low
  • ELPC $5.04
  • BLCO $12.92
  • 52 Week High
  • ELPC $7.10
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • ELPC 65.39
  • BLCO 25.26
  • Support Level
  • ELPC $6.42
  • BLCO $13.88
  • Resistance Level
  • ELPC $6.93
  • BLCO $14.70
  • Average True Range (ATR)
  • ELPC 0.12
  • BLCO 0.54
  • MACD
  • ELPC 0.03
  • BLCO -0.18
  • Stochastic Oscillator
  • ELPC 98.04
  • BLCO 2.37

About ELPC Companhia Paranaense de Energia (COPEL) (each representing four (4))

Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: